Demand Optical Preclinical Imaging Market Increasing in Most Part of World 2027

The global optical preclinical imaging market size is expected to reach USD 543.0 million by the end of 2027, expanding at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.

For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel molecules to fight antimicrobial resistance. Moreover, various researchers are engaged in finding novel ways to increase the reproducibility and robustness of preclinical cancer research with an aim to reduce the failure rate of oncology clinical trials. Optical imaging also allows cost-effective and high-throughput animal study as compared to small animal molecular imaging technologies, including PET and MRI systems.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/optical-preclinical-imaging-market

Further key findings from the study suggest:

• North America accounted for the largest share in 2019 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects
• Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2019 owing to high sensitivity and broad dynamic range as compared to other techniques for imaging animals used in various studies
• The bioluminescence segment is expected to witness significant growth over the forecast period due to increasing adoption of bioluminescence technology to visualize and study disease processes in laboratory animals
• By end use, the pharma and biotech companies segment accounted for the largest optical preclinical imaging market share in 2019 owing to increasing number of candidates in drug development studies and increasing focus on research and development for drug development and innovation
• The research institutes segment is expected to witness the fastest growth during the forecast period owing to rising adoption of advanced optical imaging systems in the research institutes
• Leading players operating in the market for optical preclinical imaging include Bruker; Perkin Elmer, Inc.; MR Solutions; BioTek Instruments, Inc.; Milabs B.V.; Fujifilm Holdings Corporation; Magnetic Insight, Inc.; MBF Bioscience; and Mediso Ltd.

Grand View Research has segmented the global optical preclinical imaging market on the basis of product type, end use, and region:

Optical Preclinical Imaging Product Type Outlook (Revenue, USD Million, 2016 - 2027)

• Device
  • Fluorescence
  • Bioluminescence
• Consumables
  • Fluorescence
    • Green fluorescent proteins
    • Red fluorescent proteins
    • Infrared dyes
    • Others
  • Bioluminescence
    • Luciferins
    • Proluciferins
    • Coelenterazine
    • Others
  • Software

Optical Preclinical Imaging End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Pharma and Biotech Companies
• Research Institutes
• Others

Optical Preclinical Imaging Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America 
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Qatar

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.